Gefticip 250mg tablet

Every medicine has some side effects that manage on their own as your body gets used to the medicine, but some people may rarely experience severe side effects. In that case, the patient should contact the doctor immediately.
Some common side effects of Entekor 1mg Tablet include:
Mouth sores
Dry skin
Loss of appetite
Blisters of skin
Vomiting
Hives on the skin
Shortness of breath
Dark coloration of urine
Yellowing of skin and eyes
Nausea
Sensitivity to light
Vision complications
Acne
Extreme weakness
Diarrhea
Seek medical attention in case of any unusual or severe side effects immediately.

The dosage and treatment duration of the Gefticip 250mg tablet are decided by the doctor according to the stage of cancer and the overall patient's health. This tablet should be taken with or without food, but at the fix time every day to get effective results. Don't miss a dose or overdose on the medicine.

​It is advisable to avoid missing any doses of Gefticip and in case you miss a dose of Gefticip consult your doctor immediately.​

At our pharmacy, your health is our top priority. All of our medicines are safe, effective, and approved by leading health authorities. We partner exclusively with reliable and reputable manufacturers, ensuring the highest quality standards in every product we deliver.

Enjoy the convenience of fast home delivery, secure packaging, and affordable prices—plus special discounts on bulk orders. We’re proud to offer international shipping to a wide range of countries across Asia, Europe, Africa, the Americas, and beyond, making trusted healthcare accessible no matter where you are.

Whether you're a patient or a healthcare provider, you can order with confidence and compassion. Our goal is to ensure that quality healthcare reaches everyone, everywhere.


We currently ship to:

Barbados, Haiti, Trinidad and Tobago, Mexico, Bahamas, Ecuador, Peru, Chile, Brazil, Colombia, Philippines, U.K., USA, Kuwait, Saudi Arabia, UAE, Oman, Qatar, Japan, Ireland, Russia, China, France, Australia, Lithuania, Nigeria, Romania, Algeria, Canada, Singapore, Thailand, Hong Kong, Bahrain, Jordan, Indonesia, Hungary, Moldova, Bulgaria, Azerbaijan, Congo, Ethiopia, Lebanon, Morocco, Mozambique, South Korea, Sri Lanka, Belarus, Mongolia, Malaysia, Vietnam, Tunisia, Zambia, and Israel.
Experience the quality everyone’s talking about – order today!

1. Uhm, J. H., Ballman, K. V., Wu, W., Giannini, C., Krauss, J. C., Buckner, J. C., ... & Jaeckle, K. A. (2011). Phase II evaluation of gefitinib in patients with newly diagnosed Grade 4 astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074. International Journal of Radiation Oncology* Biology* Physics, 80(2), 347-353.
2. Herbst, R. S., Fukuoka, M., & Baselga, J. (2004). Gefitinib—a novel targeted approach to treating cancer. Nature Reviews Cancer, 4(12), 956-965.
3. Rawluk, J., & Waller, C. F. (2018). Gefitinib. Small molecules in oncology, 235-246.
4. Giaccone, G. (2004). The role of gefitinib in lung cancer treatment. Clinical cancer research, 10(12), 4233s-4237s.
5. Höpfner, M., Sutter, A. P., Huether, A., Schuppan, D., Zeitz, M., & Scherübl, H. (2004). Targeting the epidermal growth factor receptor by gefitinib for treatment of hepatocellular carcinoma. Journal of hepatology, 41(6), 1008-1016.
6. Araki, T., Yashima, H., Shimizu, K., Aomori, T., Hashita, T., Kaira, K., ... & Yamamoto, K. (2012). Review of the treatment of non-small cell lung cancer with gefitinib. Clinical Medicine Insights: Oncology, 6, CMO-S7340.